4
Changes in Ownership
Vir Biotechnology, Inc. Filed Acc 0001628280-26-074055
SVP, Chief Accounting Officer acquired 50,000 shares (grant or award)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Sabatini Brent · SVP, Chief Accounting Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-11-15 | Grant or award : show line 1 in the form 10b5-1 | +50,000 | 111,902 | D |
Loading xslF345X06/wk-form4_1794849335.xml…